HOME >> BIOLOGY >> NEWS
Tomorrow's green nanofactories

WASHINGTON, DCViruses are notorious villains. They cause serious human diseases like AIDS, polio, and influenza, and can lead to system crashes and data loss in computers.

A new podcast explores how nanotechnology researcher Angela Belcher, from Massachusetts Institute of Technology (MIT), is working with viruses to make them do good things. By exploiting a viruss ability to replicate rapidly and combine with semiconductor and electronic materials, she is coaxing them to grow and self-assemble nanomaterials into a functional electronic device. Through this marriage of nanotechnology with green chemistry, Belcher and her team are working toward building faster, better, cheaper and environmentally-friendly transistors, batteries, solar cells, diagnostic materials for detecting cancer, and semiconductors for use in modern electrical deviceseverything from computers to cell phones.

Unlike traditional semiconductor or battery manufacturing which requires expensive and toxic chemicals, Belchers nanofactories generate little waste, grow at room temperature, and promise to be inexpensive and largely biodegradable.

Does all this sound too good to be true" Judge for yourself. Listen to an interview with Dr. Belcher, a 2004 winner of a MacArthur Foundation Genius Award. It is second in an exciting new series of podcasts called Trips to the NanoFrontier. These podcasts are available online at www.penmedia.org/podcast, or directly from Apples iTunes music store.

These podcasts and a recent publication, NanoFrontiers: Visions for the Future (www.nanotechproject.org/114), are written by freelance science writer Karen F. Schmidt. Both focus on nanotechnologys ability to address the energy crisis, the need for better medical treatments, and the demand for clean water. They are based on a two-day NanoFrontiers forecasting workshop held in Februar
'"/>

Contact: Julia Moore
julia.moore@wilsoncenter.org
202-691-4025
Project on Emerging Nanotechnologies
9-Jul-2007


Page: 1 2

Related biology news :

1. Experimental Biology 2007: Todays Research, Tomorrows Health, April 28-May 2
2. Tomorrows cancer researchers to attend the 97th Annual Meeting
3. Tomorrows endangered species: Act now to protect species not yet under threat
4. Climate change and permafrost thaw alter greenhouse gas emissions in northern wetlands
5. Clues to future evolution of HIV come from African green monkeys
6. Citrus greening continues to spread in citrus growing areas
7. NIST building software offers green product advice
8. Nanotechnology provides green path to environmentally sustainable economy
9. NASA predicts nongreen plants on other planets
10. Building green made easier with new roadmap
11. New Geisinger Health System building green Center for Health Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 30, ... ... expert tissue data insights, today announced that the launch of a new ... along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the premier provider ... Derek Fournier has been appointed CEO and President. Founder and former CEO, David ... , “DeCurtis Corporation has been on an incredible journey for the last twenty ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
Breaking Biology Technology:
Cached News: